“MB” is a frail, wheelchair-ridden, nearly blind, and mostly deaf woman living with early dementia and neglected lung cancer. What this oncologist thought MB wanted and needed was a lot different than what MB actually wanted and needed after discussing various options with her and talking to her family on numerous occasions. A humbling, honest […]
This CME program from the Cleveland Clinic Journal of Medicine explores a patient with a history of major depressive disorder, progressively worsening altered mental status, intermittent blank staring, blurred vision, bilateral incoordination of the upper and lower extremities, difficulty following commands, and decreased verbal communication. Would you rule out stroke? Serotonin syndrome? Earn some credits […]
According to Daniel A. Nation, PhD, associate professor of psychological science at University of California, Irvine: “Studies of angiotensin II receptor blockers and ACE inhibitors have suggested these medicines may confer the greatest benefit to long-term cognition, while other studies have shown the benefits of calcium channel blockers and diuretics on reducing dementia risk.”
The numbers are staggering: fifty million people worldwide live with dementia, with the number expected to reach 152 million in 2050. Despite these seemingly overwhelming totals, the neurocognitive health of you and your patients is highly dependent on multiple factors. Here are five of them, all supported by evidence-based studies.